Aeovian Pharmaceuticals logo

Aeovian Pharmaceuticals Funding & Investors

Novato, CA

Aeovian Pharmaceuticals is a San Francisco Bay Area-based biopharmaceutical company aiming to discover, develop, and commercialize innovative therapeutics for the treatment of rare and age-related diseases. The company is developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Aeovian Pharmaceuticals was founded in 2012.

aeovian.com

Total Amount Raised: $87,785,688

Aeovian Pharmaceuticals Funding Rounds

  • Series A

    $50,000,000

    Series A Investors

    Hevolution Foundation
    Apollo Ventures
    b2venture
    Evotec
    Sofinnova Ventures
    venBio Partners
  • Series A

    $37,000,000

    Series A Investors

    Apollo Ventures
    Sofinnova Ventures
    venBio Partners
    Evotec
  • Seed

    $785,687

Funding info provided by Diffbot.